Academic Mobility at the Department of Nervous Diseases

 In accordance with the memorandum of cooperation between our universities—S.D. Asfendiyarov Kazakh National Medical University (KazNMU) in Almaty, Republic of Kazakhstan, and Abu Ali ibn Sino Bukhara State Medical Institute in Bukhara, Republic of Uzbekistan—a faculty academic mobility program was implemented at the Department of Nervous Diseases from February 24 to March 1, 2025.

Discussion Club “The Simple Complexities of Pain Management: What Every Doctor Needs to Know?” on 1MedTV

On March 3, a live discussion club on the topic “The Simple Complexities of Pain Management: What Every Doctor Needs to Know?” was held on the First Medical Channel (1MedTV).

III Central Asian Neurological Forum “Current Issues in Clinical Neurology and Neurorehabilitation”

From February 28 to March 1, 2025, the III Central Asian Neurological Forum “Current Issues in Clinical Neurology and Neurorehabilitation” was held in Almaty, dedicated to the 95th anniversary of S.D. Asfendiyarov Kazakh National Medical University (KazNMU).

The Role of Adjuvants in Pain Syndrome Therapy

On February 20, a webinar on the topic “The Role of Adjuvants in Pain Syndrome Therapy” was held for neurologists, general practitioners, therapists, and residents. The webinar was conducted by the Head of the Department of Nervous Diseases at KazNMU, Chief Neurologist of the Ministry of Health of the Republic of Kazakhstan, Turupekova S.T.

Somatoform Disorders: Modern Approaches to Diagnosis and Treatment

On February 20, 2025, in Almaty, a multidisciplinary expert working meeting was held with the participation of neurologists, psychiatrists, cardiologists, and general practitioners on the topic “Somatoform Disorders: Modern Approaches to Diagnosis and Treatment”

Biotechnology in Kazakhstan: Trust, Care, Freedom!

On February 8 and 15, 2025, educational events were held in Almaty and Astana dedicated to improving the quality of life for patients with generalized myasthenia gravis (MG) and neuromyelitis optica spectrum disorder (NMOSD) through biotechnology